Results 211 to 220 of about 80,266 (330)
Snapshot Look at Castleman Disease
Journal of Cellular and Molecular Medicine, Volume 30, Issue 3, February 2026.ABSTRACT Castleman disease (CD) is a rare and heterogeneous group of lymphoproliferative disorders characterised by abnormal proliferation of lymphoid tissue. First described in the 1950s, it has since been classified into two major clinical forms: unicentric CD (UCD), involving a single lymph node region and multicentric CD (MCD), which affects ...
Ciprian Jitaru +17 more
wiley +1 more source
High Complete Responses with Combination of Platinum-Based Regimen with BTK Inhibitors in Richter's Syndrome: University of Miami - Case Series [PDF]
Georgios Pongas +4 more
openalex +1 more source
Journal of Sleep Research, Volume 35, Issue 1, February 2026.ABSTRACT This study investigates the impact of extensive visual procedural training on the temporal organisation of sleep spindles in healthy young adults. We selected 39 participants aged 16–20 and employed high‐density electroencephalography to assess spindle characteristics during two full nights of sleep, with daytime practising in a contour ...
Patrícia Gerván +4 more
wiley +1 more source
Accelerated Chronic Lymphocytic Leukaemia Complicated by Bilateral Pathological Humeral Fractures
eJHaem, Volume 7, Issue 1, February 2026.
Mariyum Khawar +3 more
wiley +1 more source
DNA methyltransferase inhibitors in hematological malignancies and solid tumors
International Journal of Cancer, Volume 158, Issue 2, Page 433-461, 15 January 2026.Abstract Epigenetic modifications such as DNA methylation play a fundamental role in oncogenesis and the progression of neoplasms neoplasias. DNA methyltransferase inhibitors (DNMTi) constitute a family of therapeutic agents that impede the methylation at the 5‐position on cytosine nucleotides, thereby modulating the epigenetic regulation of tumor ...
Valentin Wenger +3 more
wiley +1 more source
Tec regulates platelet activation by GPVI in the absence of Btk [PDF]
, 2003 Ben Atkinson +2 more
openalex +1 more source
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK) [PDF]
, 2019 Scott H. Watterson +42 more
openalex +1 more source